Anti-human VEGF (Ranibizumab Biosimilar) Size:1 mg Protein S100 B

Protein S100 B

4 mg/ml of each protein in the buffer

3ml RTU -20°C 9 Counter Staining Reagent 5ml RTU RT 10 Differentiation Reagent 6ml RTU RT 11 Mounting Media 5ml RTU RT 12 Control slide (Human pancreas) 1 slide RTU RT 13 Datasheet 1 copy

and it complexes with CD29 (Integrin beta 1) to form the heterodimeric integrin VLA-2 (integrin alpha 2 beta 1

Anti-human VEGF (Ranibizumab Biosimilar) Size:1 mg Protein S100 BApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name VEGF Target Uniprot P15692 Overview Catalog# BIO0830SM Product Name Anti human VEGF (Ranibizumab Biosimilar) Specifications Conjugation None Clone# Ranibizumab Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with sterile ddH2O Concentration